Prudential Financial Inc Castle Biosciences Inc Transaction History

Prudential Financial Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$11.66 - $26.0 $95,612 - $213,200	-8,200 Reduced 35.71%	14,765 $202,000
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $223,905 - $327,635	11,500 Added 100.31%	22,965 $521,000
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $207,287 - $343,950	11,465 New	11,465 $0
Q1 2022 May 13, 2022	SELL	$33.17 - $46.98 $141,669 - $200,651	-4,271 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $22,850 - $39,534	-585 Reduced 12.05%	4,271 $256,000
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $57,424 - $74,108	955 Added 24.48%	4,856 $375,000
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $195,323 - $299,518	3,901 New	3,901 $286,000
Q4 2020 Feb 16, 2021	SELL	$43.6 - $73.05 $18,704 - $31,338	-429 Closed	0 $0
Q3 2020 Aug 05, 2021	SELL	$38.47 - $52.03 $2.15 Million - $2.91 Million	-55,961 Reduced 99.24%	429 $22,000
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $803,715 - $1.09 Million	20,892 Added 58.85%	56,390 $2.9 Million
Q2 2020 Aug 12, 2020	BUY	$27.28 - $43.01 $712,062 - $1.12 Million	26,102 Added 277.8%	35,498 $1.34 Million
Q1 2020 May 12, 2020	BUY	$23.08 - $35.53 $216,859 - $333,839	9,396 New	9,396 $280,000

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $752M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.